Licensing of cutting-edge technologies
Lophius Biosciences is always interested in new technologies and products that are available for licensing to expand our current immunodiagnostic product portfolio. Our strategic approach involves the evaluation of in-licensing opportunities for cutting-edge technologies and products in the area of T cell immunology. We are also open to provide access to Lophius proprietary T-activation® and Reverse T cell Technologies.
Become a distribution partner
Shape the future of efficient CMV immunodiagnostic and become a distribution partner for our in vitro diagnostic ELISpot kit T-Track® CMV in various regions of the world. Benefit from our extensive experience in development, clinical validation and marketing of this highly-sensitive immune-monitoring tool, that measures the reactivity of IFN-γ-producing effector cells against CMV antigens.
Please fill out the form below if you are interested in becoming a distribution partner and you will receive a company information brochure. A company representative will follow up with you shortly.